MNKD - CIK 0000899460
MANNKIND CORP trades as MNKD and has a market capitalization of $1.11 B, making it the #2559 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $348.97M, up 22.2% from the prior year and net income of $5.86M. This page tracks MANNKIND CORP through 1,648 SEC filings, with financial statements and metrics updated as new reports are filed.
Over the last 9 fiscal years MANNKIND CORP's revenue grew from $174.76M to $348.97M, a compound annual growth rate of 8.0%. Net profit margin compressed from 71.9% to 1.7% over the same period - every figure below comes from the company's audited annual filings.
| Filing | Type | Filed |
|---|---|---|
| Insider trade | 4 | 2026-05-22 |
| Insider trade | 4 | 2026-05-22 |
| Insider trade | 4 | 2026-05-22 |
| Insider trade | 4 | 2026-05-22 |
| Insider trade | 4 | 2026-05-22 |
| Insider trade | 4 | 2026-05-22 |
| Insider trade | 4 | 2026-05-22 |
| Insider trade | 4 | 2026-05-22 |
MannKind to Host Conference Call Today to Discuss Afrezza Pediatric Approval | MannKind Corporation
MannKind Announces FDA Approval of Afrezza®, the First and Only Inhaled Mealtime Insulin for Use in Children and Adolescents Aged 6 and Older Living with Diabetes | MannKind Corporation
MannKind to Showcase New Data at ADA 2026 Advancing Understanding of Inhaled Insulin (Afrezza®) in Pediatric Care, Pregnancy and Use with Automated Insulin Delivery (AID) Systems | MannKind Corporation
MannKind Reports First Quarter 2026 Financial Results and Provides Business Update | MannKind Corporation
MannKind to Present New Data From Pediatric and Adult Studies of Afrezza® at ATTD 2026 | MannKind Corporation
The largest companies sharing MANNKIND CORP's SEC industry classification (pharmaceutical preparations).
MANNKIND CORP (MNKD) has a market capitalization of $1.11 B as of 2026-06-10, ranking #2559 among US-listed companies.
MANNKIND CORP reported revenue of $348.97M for fiscal year 2025, an increase of 22.2% year over year.
Yes. MANNKIND CORP reported net income of $5.86M in its latest fiscal year.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.